Publication | Closed Access

Thymoquinone alleviates thioacetamide-induced hepatic fibrosis and inflammation by activating LKB1–AMPK signaling pathway in mice

InflammationThioacetamide-induced Hepatic FibrosisAnti-inflammatoryHepatologyAllergyMedicineLiver PhysiologyImmunologyChronic InflammationHepatotoxicityHepatology FibrosisPharmacologyCell SignalingDrug-induced Liver InjuryOxidative Stress